PATIENTS & FAMILIES HEALTHCARE PROFESSIONALS INVESTORS MEDIA ABOUT US Home About us Company profile Company profile We are the leading provider of products and services for individuals with renal diseases. © Fresenius Medical Care AG & Co. KGaA 2021 Fresenius Medical Care uses cookies on this website to enhance the user experience, provide the best possible service, analyze site usage and for marketing purposes. By clicking “Accept All”, you agree to the storing of store such cookies on your device. By clicking “Reject all”, only strictly necessary cookies will be used. For more information please see our Cookies Settings Reject All Accept All

PATIENTS & FAMILIES HEALTHCARE PROFESSIONALS INVESTORS MEDIA ABOUT US Home Investors Shares Share buy-back Share buy-back Share buy-back 2019 On June 17, 2019 we commenced, as announced on June 14, 2019, our share buy-back program on the basis of the authorization by the Annual General Meeting 2016. In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €659 million (excluding fees) were repurchased in the period from June 17, 2019 until April 1, 2020. Accordingly, the share buy-back program was fully completed on April 1, 2020. In the following we inform you about the number of shares acquired in the context of the share buy-back program. © Fresenius Medical Care AG & Co. KGaA 2021 Fresenius Medical Care uses cookies on this website to enhance the user experience, provide the best possible service, analyze site usage and for marketing purposes. By clicking “Accept All”, you agree to the storing of store such cookies on your device. By clicking “Reject all”, only strictly necessary cookies will be used. For more information please see our Cookies Settings Reject All Accept All

PATIENTS & FAMILIES HEALTHCARE PROFESSIONALS INVESTORS MEDIA ABOUT US Home About us Supervisory Board Supervisory Board Fresenius Medical Care AG & Co. KGaA Next © Fresenius Medical Care AG & Co. KGaA 2021

PATIENTS & FAMILIES HEALTHCARE PROFESSIONALS INVESTORS MEDIA Home Investors News News You are interested in our news? Newsroom 11/02/2021 Press release Fresenius Medical Care confirms outlook for 2021 while considering the continued negative impact of COVID-19 © Fresenius Medical Care AG & Co. KGaA 2021 Fresenius Medical Care uses cookies on this website to enhance the user experience, provide the best possible service, analyze site usage and for marketing purposes. By clicking “Accept All”, you agree to the storing of store such cookies on your device. By clicking “Reject all”, only strictly necessary cookies will be used. For more information please see our Cookies Settings Reject All Accept All